You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous Squamous Cell Carcinoma in situ

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Worldwide (BIBF 1120, Placebo)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • BIBF 1120
  • Placebo
  • Milano, Italy
  • +6 more
Sep 3, 2018

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Sickle Cell Disease Trial in Atlanta (Biotin Labeled Red Blood Cells)

Recruiting
  • Sickle Cell Disease
  • Biotin Labeled Red Blood Cells
  • Atlanta, Georgia
  • +2 more
Nov 1, 2021

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Beijing, Beijing, China
  • +13 more
Aug 16, 2022

Sickle Cell Disease Trial in Durham (AB1)

Not yet recruiting
  • Sickle Cell Disease
  • Durham, North Carolina
    Duke University Medical Center
Jul 21, 2022

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University of Frankfurt, Medical Dept. II
Aug 17, 2022

Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
May 20, 2023

Melanoma Trial (Tranexamic acid, Saline)

Not yet recruiting
  • Melanoma
  • (no location specified)
Jun 2, 2023

Treatment-na?ve Mantle Cell Lymphoma Trial in China (Orelabrutinib and R-CHOP, R-CHOP)

Not yet recruiting
  • Treatment-naїve Mantle Cell Lymphoma
  • Hefei, Anhui, China
  • +21 more
Dec 8, 2021

Camrelizumab in Unresectable Hepatocellular Carcinoma

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • (no location specified)
Jun 29, 2021

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Lung Tumor Malignant Trial in Milano (SBRT, Surgery)

Not yet recruiting
  • Lung Neoplasm Malignant
  • SBRT
  • Surgery
  • Milano, MI, Italy
    Istituto Europeo di Oncologia IRCCS
Jul 26, 2023

Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)

Recruiting
  • Radiotherapy
  • +3 more
  • Beijing, Beijing, China
    Bo Chen
Mar 6, 2021

Advanced Solid Tumor, Relapsed/Refractory Lymphoma Trial in Beijing (OVV-01 Injection+IBR900 Cell Injection)

Recruiting
  • Advanced Solid Tumor
  • Relapsed/Refractory Lymphoma
  • OVV-01 Injection+IBR900 Cell Injection
  • Beijing, Beijing, China
    Beijing Boren Hospital
Mar 4, 2022

Coronary Heart Disease Trial in China (MiStent, TIVOLI)

Unknown status
  • Coronary Heart Disease
  • MiStent
  • TIVOLI
  • Changsha, Hunan, China
  • +15 more
Sep 3, 2020

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Liver Transplantation Trial in Seoul (Immuncell-LC)

Recruiting
  • Liver Transplantation
  • Immuncell-LC
  • Seoul, Korea, Republic of
    Seoul National Hospital
Apr 14, 2021

NSCLC Trial in Beijing (SY-3505)

Recruiting
  • Non-small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Mar 17, 2022

Chronic Leukemia Trial in France (Additional biological samples)

Active, not recruiting
  • Chronic Leukemia
  • Additional biological samples
  • Besançon, France
  • +3 more
May 31, 2022

Patient With Anti-GABAbr Antibodies Associated-encephalitis.

Completed
  • Autoimmune Encephalitis
  • Long-term outcome
  • Lyon, France
    Centre de référence des syndromes neurologiques paranéoplasiques
Feb 14, 2023

Long COVID-19 Syndrome Trial in Shenzhen (MSC-derived exosomes)

Recruiting
  • Long COVID-19 Syndrome
  • MSC-derived exosomes
  • Shenzhen, Guangdong, China
    Huazhong University of Science and Technology Union Shenzhen Hos
Apr 12, 2023

Congenital Heart Disease (CHD) Trial in Washington (BM-MSC)

Recruiting
  • Congenital Heart Disease (CHD)
  • BM-MSC
  • Washington, District of Columbia
    Children's National Health System
May 11, 2022